TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
ICLR

ICON PLC

Healthcare · Diagnostics & Research

164.50$ +0.3% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

ICON PLC (ICLR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 16,400 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ICLR
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,900 1,826 1,855 1,904 2,053 2,186 2,219 2,174 2,326 2,386 2,607 2,719 2,745 2,908 2,841 2,859 3,065 3,436 3,467 3,584 17,655 17,387 17,163 17,036 17,126 17,185 17,287 17,108 17,031 16,990 17,048 16,969 17,211 16,878 16,723 16,602 16,507 16,270 16,319 16,400
1,009 958 982 1,025 1,002 1,101 1,164 1,149 1,306 1,344 1,441 1,467 1,480 1,625 1,556 1,578 1,771 2,103 2,169 2,285 3,130 2,941 2,870 2,930 3,172 3,229 3,429 3,368 3,421 3,411 3,555 3,604 3,779 3,530 3,416 3,309 3,409 3,502 3,607 3,749
219 193 237 228 210 283 272 289 426 396 418 370 418 520 482 592 708 840 942 1,055 1,009 752 559 615 609 289 280 270 313 378 396 507 696 539 527 390 469 647 765 928
304 261 319 315 292 360 354 373 491 456 478 431 471 570 484 594 710 842 944 1,057 1,010 754 561 617 611 290 282 272 315 380 398 507 696 539 527 390 469 – 765 928
666 662 625 671 667 706 764 752 772 856 923 995 965 1,014 1,029 946 1,018 1,207 1,138 1,157 1,988 2,073 2,158 2,183 2,431 2,801 2,978 2,943 2,956 2,899 3,008 2,958 2,943 2,851 2,736 2,776 2,799 1,475 2,698 2,705
2.4 2.4 – – – 2.2 0.0 – 0.0 2.3 – – 3.2 3.2 3.2 0.0 – 4.8 – 0.0 0.0 5.8 – – 7.1 7.1 – – 0.0 -2.9 -2.9 0.0 0.0 – – – – – – –
151 149 149 150 152 163 161 155 155 159 267 265 264 270 262 249 246 259 240 235 558 535 510 474 453 504 499 – 475 – – – – – – – – – – –
627 616 618 626 764 783 776 759 761 770 787 855 877 883 893 901 914 936 928 933 8,935 9,038 9,028 8,970 8,943 8,972 8,979 8,994 8,983 9,022 9,018 9,017 9,085 9,051 9,065 9,092 8,927 8,732 8,726 8,721
64 57 52 48 74 130 67 60 54 109 58 74 66 68 79 73 69 66 61 57 4,815 4,711 4,593 4,508 4,392 4,279 4,164 4,050 3,935 3,856 3,749 3,632 3,606 3,560 3,501 3,443 3,384 3,247 3,197 3,146
909 881 911 875 926 956 1,014 936 991 1,000 1,185 1,223 1,243 1,289 1,327 1,280 1,354 1,585 1,532 1,557 9,686 9,320 9,094 8,890 8,887 8,687 8,633 8,311 8,072 7,749 7,616 7,384 7,437 7,355 7,222 7,047 7,173 7,076 7,019 7,022
458 273 516 487 527 566 628 548 602 628 712 709 729 1,131 1,209 1,170 1,243 1,124 1,080 1,105 2,301 2,479 2,541 2,482 2,731 2,691 2,899 2,760 2,871 2,826 2,946 2,742 2,819 2,796 2,689 2,557 3,219 3,196 3,170 3,935
14 199 22 20 17 257 23 14 16 335 57 58 28 378 350 350 350 24 17 9.4 55 105 55 55 55 99 135 105 130 147 80 30 30 67 30 30 568 – 530 1,280
5.1 8.7 14 7.9 13 19 12 15 15 13 19 20 21 24 23 33 29 51 48 38 63 91 64 78 61 81 85 47 87 595 114 83 106 705 118 95 113 781 100 118
401 349 349 349 349 349 349 349 349 349 349 349 350 – – – – 348 349 350 5,873 5,381 5,087 4,991 4,795 4,599 4,354 4,207 3,912 3,665 3,420 3,408 3,402 3,396 3,390 3,384 2,879 2,873 2,867 2,111
992 945 945 1,030 1,128 1,191 1,205 1,239 1,334 1,386 1,422 1,496 1,502 1,618 1,514 1,578 1,711 1,850 1,934 2,028 7,969 8,067 8,069 8,146 8,239 8,498 8,654 8,796 8,959 9,241 9,433 9,585 9,774 9,523 9,501 9,555 9,335 9,193 9,300 9,378
624 588 569 623 697 743 735 790 872 980 952 1,003 1,020 1,110 1,022 1,070 1,162 1,263 1,360 1,434 1,340 1,416 1,428 1,544 1,704 1,821 1,938 2,054 2,217 2,434 2,621 2,768 2,865 2,725 2,629 2,562 2,314 2,122 2,227 2,299
57 56 55 55 55 55 55 55 55 54 54 54 55 54 54 53 53 53 53 53 81 83 83 82 82 82 83 83 83 83 83 83 83 82 82 80 78 77 77 77

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?